Corium: Corium launches transdermal patch for treating Alzheimer's

Corium (Nasdaq:CORI) today announced the availability of Adlarity (donepezil transdermal system) for prescription use in the U.S. Adlarity, a once-weekly patch, delivers consistent doses of donepezil through the skin. It treats patients with mild, moderate, or severe dementia of the Alzheimer's type. It holds FDA approval - the first and only - for 5 mg/day [...]The post Corium launches transdermal patch for treating Alzheimer's appeared first on Drug Delivery Business.